Neuland Laboratories Q1FY18 standalone net profit declines 75.9% yoy

India Infoline Research Team | September 11, 2017 16:38 IST

Neuland Laboratories Ltd Q1FY18

Standalone Results Q1FY18: (Rs. in crore)

Q1FY18 YoY (%)
Revenue 117.5 [22.5]
EBITDA 10.63 [56.6]
EBITDA Margin (%) 9 [713]
Net Profit (adjusted) 2.29 [75.9]
***EBITDA margin change is bps
View

Accumulate

Reco. Price

1235.35

Last updated on

04-Sep-2017


Neuland Laboratories’ standalone revenue for the quarter came in at Rs. 117.5 crore, registering 22.5% yoy decline.

EBITDA for the quarter fell by 56.6% yoy to Rs. 10.63 crore with a corresponding margin contraction of 713 bps. EBITDA margin for the quarter stood at 9%. This margin contraction was led by increase in manufacturing expenses and other expenses by 32.5% yoy and 31% yoy.

The PAT for the quarter came in at Rs. 2.29 crore, yoy decline of 75.9%.



Technical View:

Neuland Laboratories Ltd is currently trading at Rs. 1,212, up by 3.25 points or 0.27% from its previous closing of Rs. 1,208.75 on the BSE.
The scrip opened at Rs. 1,212.30 and has touched a high and low of Rs. 1,224 and Rs. 1,203.30 respectively. So far 8,131(NSE+BSE) shares were traded on the counter. The stock is currently trading above its 100 DMA.

BSE 1,104.05 [41.75] ([3.64]%)
NSE 1,104.60 [35.30] ([3.10]%)

***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.